Cargando…
Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
Infliximab is a monoclonal antibody that antagonizes the activity of tumor necrosis factor alpha to induce and maintain remission in patients with inflammatory bowel disease. Adverse effects associated with Infliximab infusions include infusion reactions, risk of infections, development of hematolog...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Kare Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864712/ https://www.ncbi.nlm.nih.gov/pubmed/29607436 http://dx.doi.org/10.14744/nci.2017.77045 |